The chronic administration of cerebrolysin induces plastic changes in the prefrontal cortex and dentate gyrus in aged mice

Synapse

Volumn 65, Issue 11, 2011, Pages 1128-1135

  Juárez, Ismael ^a   González, Deniss Janeth ^a   Mena, Raúl ^b   Flores, Gonzalo ^a  

^a BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Aging process; Cerebrolysin; Dendritic morphology; Hippocampus; Neuronal plasticity; Nucleus accumbens; Prefrontal cortex

Indexed keywords

CEREBROLYSIN;

ANIMAL EXPERIMENT; ARTICLE; CELL DENSITY; CELL STRUCTURE; CONTROLLED STUDY; DENDRITE; DENTATE GYRUS; GOLGI STAIN; GRANULE CELL; HIPPOCAMPAL CA1 REGION; LEARNING; LOCOMOTION; MALE; MEMORY; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL;

AGING; AMINO ACIDS; ANIMALS; DENTATE GYRUS; MALE; MICE; MOTOR ACTIVITY; NEURONAL PLASTICITY; PREFRONTAL CORTEX;

EID: 80052380056     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20950     Document Type: Article

References (62)

1. Alquicer G, Morales-Medina JC, Quirion R, Flores G. 2008. Postweaning social isolation enhances morphological changes in the neonatal ventral hippocampal lesion rat model of psychosis. J Chem Neuroanat 35: 179-187.
2. Alvarez XA, Cacabelos R, Laredo M, Couceiro V, Sampedro C, Varela M, Corzo L, Fernandez-Novoa L, Vargas M, Aleixandre M, Linares C, Granizo E, Muresanu D, Moessler H. 2006. A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease. Eur J Neurol 13: 43-54.
3. Aoki C, Mahadomrongkul V, Fujisawa S, Habersat R, Shirao T. 2007. Chemical and morphological alterations of spines within the hippocampus and entorhinal cortex precede the onset of Alzheimer's disease pathology in double knock-in mice. J Comp Neurol 505: 352-362.
4. Biesenbach G, Grafinger P, Eichbauer-Sturm G, Zazgornik J. 1997. Cerebrolysin in treatment of painful diabetic neuropathy. Wien Med Wochenschr 147: 63-66.
5. Chen H, Tung YC, Li B, Iqbal K, Grundke-Iqbal I. 2007. Trophic factors counteract elevated FGF-2-induced inhibition of adult neurogenesis. Neurobiol Aging 28: 1148-1162.
6. Doppler E, Rockenstein E, Ubhi K, Inglis C, Mante M, Adame A, Crews L, Hitzl M, Moessler H, Masliah E. 2008. Neurotrophic effects of Cerebrolysin in the Mecp2(308/Y) transgenic model of Rett syndrome. Acta Neuropathol 116: 425-437.
7. Eder P, Reinprecht I, Schreiner E, Skofitsch G, Windisch M. 2001. Increased density of glutamate receptor subunit 1 due to Cerebrolysin treatment: An immunohistochemical study on aged rats. Histochem J 33: 605-612.
8. Einstein G, Buranosky R, Crain BJ. 1994. Dendritic pathology of granule cells in Alzheimer's disease is unrelated to neuritic plaques. J Neurosci 14: 5077-5088.
9. Ferrer I, Gullotta F. 1990. Down's syndrome and Alzheimer's disease: Dendritic spine counts in the hippocampus. Acta Neuropathol 79: 680-685.
10. Flores G, Alquicer G, Silva-Gomez AB, Zaldivar G, Stewart J, Quirion R, Srivastava LK. 2005. Alterations in dendritic morphology of prefrontal cortical and nucleus accumbens neurons in post-pubertal rats after neonatal excitotoxic lesions of the ventral hippocampus. Neuroscience 133: 463-470.
11. Francis-Turner L, Valousková V. 1996. Nerve growth factor and nootropic drug Cerebrolysin but not fibroblast growth factor can reduce spatial memory impairment elicited by fimbria-fornix transection: Short-term study. Neurosci Lett 202: 193-196.
12. Gibb R, Kolb B. 1998. A method for vibratome sectioning of Golgi-Cox stained whole rat brain. J Neurosci Methods 79: 1-4.
13. Gschanes A, Windisch M. 1999. Early postnatal treatment with peptide preparations influences spatial navigation of young and adult rats. Behav Brain Res 100: 161-166.
14. Gutmann B, Hutter-Paier B, Skofitsch G, Windisch M, Gmeinbauer R. 2002. In vitro models of brain ischemia: The peptidergic drug cerebrolysin protects cultured chick cortical neurons from cell death. Neurotox Res 4: 59-65.
15. Hartbauer M, Hutter-Paie B, Windisch M. 2001. Effects of Cerebrolysin on the outgrowth and protection of processes of cultured brain neurons. J Neural Transm 108: 581-592.
16. Huttenlocher PR. 1984. Synapse elimination and plasticity in developing human cerebral cortex. Am J Ment Defic 88: 488-496.
17. Juarez I, Gratton A, Flores G. 2008. Ontogeny of altered dendritic morphology in the rat prefrontal cortex, hippocampus and nucleus accumbens following Caesarean delivery and birth anoxia. J Comp Neurol 507: 1734-1747.
18. Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, Sisodia S, Malinow R, 2003. APP processing and synaptic function. Neuron 2003; 37: 925-937.
19. Knafo S, Alonso-Nanclares L, Gonzalez-Soriano J, Merino-Serrais P, Fernaud-Espinosa I, Ferrer I, Defelipe J. 2009. Widespread changes in dendritic spines in a model of Alzheimer's disease. Cereb Cortex 19: 586-592.
20. Knobloch M, Mansuy IM. 2008. Dendritic spine loss and synaptic alterations in Alzheimer's disease. Mol Neurobiol 37: 73-82.
21. Kolb B, Forgie M, Gibb R, Gorny G, Rowntree S. 1998. Age, experience and the changing brain. Neurosci Biobehav Rev 22: 143-159.
22. Koo EH, Lansbury PT Jr, Kelly JW. 1999. Amyloid diseases: Abnormal protein aggregation in neurodegeneration. Proc Natl Acad Sci USA 96: 9989-9990.
23. Mallory M, Honer W, Hsu L, Johnson R, Rockenstein E, Masliah E. 1999. In vitro synaptotrophic effects of Cerebrolysin in NT2N cells. Acta Neuropathol 97: 437-446.
24. Martínez-Tellez R, Gómez-Villalobos MJ, Flores G. 2005. Alteration in dendritic morphology of cortical neurons in rats with diabetes mellitus induced by streptozotocin. Brain Res 1048: 108-115.
25. Martínez-Téllez RI, Hernández-Torres E, Gamboa C, Flores G. 2009. Prenatal stress alters spine density and dendritic length of nucleus accumbens and hippocampus neurons in rat offspring. Synapse 63: 794-804.
26. Mattson MP. 2009. Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders. Exp Gerontol 2009; 44: 625-633.
27. McAllister AK. 2000. Cellular and molecular mechanisms of dendrite growth. Cereb Cortex 10: 963-973.
28. Mimura M. 2008. Memory impairment and awareness of memory deficits in early-stage Alzheimer's disease. Tohoku J Exp Med 215: 133-40.
29. Patocková J, Krsiak M, Marhol P, Tůmová E. 2003. Cerebrolysin inhibits lipid peroxidation induced by insulin hypoglycemia in the brain and heart of mice. Physiol Res 52: 455-460.
30. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates, 2nd ed. New York: Academic Press.
31. Plosker GL, Gauthier S. 2009. Cerebrolysin: A review of its use in dementia. Drugs Aging 26: 893-915.
32. Radzivil MG, Bashina VM. 2006. An effect of long-term cerebrolysin therapy in combination with neuroleptics on behavioral and cognitive disturbances in endogenous childhood autism. Zh Nevrol Psikhiatr Im S S Korsakova 106: 21-25.
33. Reinprecht I, Gschanes A, Windisch M, Fachbach G. 1999. Two peptidergic drugs increase the synaptophysin immunoreactivity in brains of 24-month-old rats. Histochem J 31: 395-401.
34. Robinson TE, Kolb B. 1997. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci 17: 8491-8497.
35. Rockenstein E, Mallory M, Mante M, Alford M, Windisch M, Moessler H, Masliah E. 2002. Effects of Cerebrolysin on amyloid-beta deposition in a transgenic model of Alzheimer's disease. J Neural Transm Suppl 62: 327-236.
36. Rockenstein E, Adame A, Mante M, Moessler H, Windisch M, Masliah E. 2003. The neuroprotective effects of Cerebrolysin in a transgenic model of Alzheimer's disease are associated with improved behavioral performance. J Neural Transm 110: 1313-1327.
37. Rockenstein E, Adame A, Mante M, Larrea G, Crews L, Windisch M, Moessler H, Masliah E. 2005. Amelioration of the cerebrovascular amyloidosis in a transgenic model of Alzheimer's disease with the neurotrophic compound cerebrolysin. J Neural Transm 112: 269-282.
38. Rockenstein E, Torrance M, Mante M, Adame A, Paulino A, Rose JB, Crews L, Moessler H, Masliah E. 2006. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease J Neurosci Res 83: 1252-1261.
39. Rockenstein E, Mante M, Adame A, Crews L, Moessler H, Masliah E. 2007. Effects of Cerebrolysin on neurogenesis in an APP transgenic model of Alzheimer's disease. Acta Neuropathol 113: 265-275.
40. Rüther E, Ritter R, Apecechea M, Freytag S, Windisch M. 1994. Efficacy of the peptidergic nootropic drug cerebrolysin in patients with senile dementia of the Alzheimer type (SDAT). Pharmacopsychiatry 27: 32-40.
41. Satou T, Itoh T, Tamai Y, Ohde H, Anderson AJ, Hashimoto S. 2000. Neurotrophic effects of FPF-1070 (Cerebrolysin) on cultured neurons from chicken embryo dorsal root ganglia, ciliary ganglia, and sympathetic trunks. J Neural Transm 107: 1253-1262.
42. Schauer E, Wronski R, Patockova J, Moessler H, Doppler E, Hutter-Paier B, Windisch M. 2006. Neuroprotection of cerebrolysin in tissue culture models of brain ischemia: Post lesion application indicates a wide therapeutic window. J Neural Transm 113: 855-868.
43. Scheff SW, Price DA, Schmitt FA, DeKosky ST, Mufson EJ. 2007. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 68: 1501-1508.
44. Sesack SR, Grace AA. 2010. Cortico-basal ganglia reward network: Microcircuitry. Neuropsychopharmacology 35: 27-47.
45. Sharma HS, Zimmermann-Meinzingen S, Johanson CE. 2010a. Cerebrolysin reduces blood-cerebrospinal fluid barrier permeability change, brain pathology, and functional deficits following traumatic brain injury in the rat. Ann N Y Acad Sci 1199: 125-137.
46. Sharma HS, Zimmermann-Meinzingen S, Sharma A, Johanson CE. 2010b. Cerebrolysin attenuates blood-brain barrier and brain pathology following whole body hyperthermia in the rat. Acta Neurochir Suppl 106: 32132-32135.
47. Shim KS, Lubec G. 2002. Drebrin, a dendritic spine protein, is manifold decreased in brains of patients with Alzheimer's disease and Down syndrome. Neurosci Lett 324: 209-212.
48. Sholl DA. 1953. Dendritic organization in the neurons of the visual and motor cortices of the cat. J Anat 87: 387-406.
49. Silva-Gomez AB, Rojas D, Juarez I, Flores G. 2003. Decreased dendritic spine density on prefrontal cortical and hippocampal pyramidal neurons in postweaning social isolation rats. Brain Res 983: 128-136.
50. Sinha S, Anderson J, John V, McConlogue L, Basi G, Thorsett E, Schenk D. 2000. Recent advances in the understanding of the processing of APP to beta amyloid peptide. Ann N Y Acad Sci 920: 206-208.
51. Solis O, Vázquez-Roque RA, Camacho-Abrego I, Gamboa C, De La Cruz F, Zamudio S, Flores G. 2009. Decreased dendritic spine density of neurons of the prefrontal cortex and nucleus accumbens and enhanced amphetamine sensitivity in postpubertal rats after a neonatal amygdala lesion. Synapse 63: 1143-1153.
52. Solis O, Limón DI, Flores-Hernández J, Flores G. 2007. Alterations in dendritic morphology of the prefrontal cortical and striatum neurons in the unilateral 6-OHDA-rat model of Parkinson's disease. Synapse 61: 450-458.
53. Spires-Jones TL, Meyer-Luehmann M, Osetek JD, Jones PB, Stern EA, Bacskai BJ, Hyman BT. 2007. Impaired spine stability underlies plaque-related spine loss in an Alzheimer's disease mouse model. Am J Pathol 171: 1304-1311.
54. Tatebayashi Y, Lee MH, Li L, Iqbal K, Grundke-Iqbal I. 2003. The dentate gyrus neurogenesis: A therapeutic target for Alzheimer's disease. Acta Neuropathol 105: 225-232.
55. Thierry AM, Gioanni Y, Degenetais E, Glowinski J. 2000. Hippocampo-prefrontal cortex pathway: Anatomical and electrophysiological characteristics. Hippocampus 10: 411-419.
56. Uylings HB, de Brabander JM. 2002. Neuronal changes in normal human aging and Alzheimer's disease. Brain Cogn 49: 268-276.
57. Vega E, Gomez-Villalobos MJ, Flores G. 2004. Alteration in dendritic morphology of pyramidal neurons from the prefrontal cortex of rats with renovascular hypertension. Brain Res 1021: 112-118.
58. Veinbergs I, Mante M, Mallory M, Masliah E. 2000. Neurotrophic effects of Cerebrolysin in animal models of excitotoxicity. J Neural Transm Suppl 59: 273-280.
59. Wei J, Fujita M, Nakai M, Waragai M, Watabe K, Akatsu H, Rockenstein E, Masliah E, Hashimoto M. 2007. Enhanced lysosomal pathology caused by beta-synuclein mutants linked to dementia with Lewy bodies. J Biol Chem 282: 28904-28914.
60. Wenzel J, Stender G, Duwe G. 1981. Development of neuron structure of the fascia dentata in the rat. Neurohistologico-morphometric, ultrastructural and experimental study. J Hirnforsch 22: 629-683.
61. Wronski R, Tompa P, Hutter-Paier B, Crailsheim K, Friedrich P, Windisch M. 2000. Inhibitory effect of a brain derived peptide preparation on the Ca++-dependent protease, calpain. J Neural Transm 107: 145-157.
62. Ziganshina LE, Abakumova T, Kuchaeva A. 2010. Cerebrolysin for acute ischaemic stroke. Cochrane Database Syst Rev 4: CD007026.